Related Experiment Video
Updated: Jan 13, 2026

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Polysaccharides from Citrus Fruit with Different Mastication Traits Ameliorate DSS-Induced Ulcerative Colitis by
Jieqiong Yao1,2,3, Siyi Pan1,2,3
1College of Food Science and Technology, Huazhong Agricultural University, Wuhan 430070, China.
None:
Mastication trait is an important indicator for evaluating citrus fruit texture and may modulate the biological activity of citrus polysaccharides. This study compared the protective effects of pulp polysaccharides from citrus fruit with different mastication traits, namely Hongmeiren (HMR, superior), Satsuma (WM, moderate), and Nanfeng tangerine (NF, inferior mastication trait) on ulcerative colitis (UC) in mice. All polysaccharides alleviated UC symptoms, with HMR showing the most pronounced effects by more markedly reducing TNF-α levels, while enhancing IL-10, ZO-1, Occludin, and MUC2 expression. NF exhibited a stronger inhibitory effect on IL-6. Microbiota analysis revealed that citrus polysaccharides suppressed Escherichia-Shigella and Helicobacter, enriched Akkermansia and norank_f_Muribaculaceae, and promoted short-chain fatty acid production, particularly of propionate and butyrate. LEfSe analysis further indicated that HMR selectively enriched Dubosiella and norank_o_Clostridia_UCG-014, WM increased the abundance of Lachnospiraceae_NK4A136_group, and NF promoted the growth of Parabacteroides. Overall, HMR with superior mastication trait exhibited the greatest efficacy in attenuating inflammation and maintaining intestinal homeostasis. These findings reveal an intrinsic link between citrus mastication traits and their colitis-alleviating activity, offering a mechanistic basis for dietary intervention in inflammatory bowel disease as well as for functional citrus breeding.
Related Concept Videos
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Ulcerative Colitis in IBD
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Drugs for Treatment of Constipation-Predominant IBS
Mucosal Barrier of the Stomach
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...

